Document is current
Any future updates will be listed below
-
Authors
Iimura, Jun
Shobako, Naohisa
Yagibashi, Masahiro
Nakajima, Atsushi
Fujii, Shintaro
Nakazeko, Takuo
Hirano, Yukio
Nakamura, Futoshi
Honda, Keiko
- License Information
-
More Information
Article History
Received: 20 October 2025
Accepted: 27 February 2026
First Online: 9 March 2026
Declarations
:
: Ethics are shown in Section “2.1, Study design”. The human clinical studies described in this article were conducted in accordance with the principles of the Declaration of Helsinki, with approval from the Ethics Review Board of the Ueno Asagao Clinic on November 13, 2023 (2023-34) in accordance with the ethical guidelines for human research (Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor and Welfare, Japan). The trial was registered with the UMIN Clinical Trials Registry (UMIN000052973). Informed consent was obtained from the individuals in a written, documented.
: Jun Iimura, Naohisa Shobako, Takuo Nakazeko, Yukio Hirano, and Futoshi Nakamura were all employed by Nissin Food Holdings. Atsushi Nakajima, and Keiko Honda have no financial interests. Nissin Foods Products Co., Ltd. funded the study and contracted TES Holdings Co., Ltd. to conduct trial operations and statistical analyses. Masahiro Yagihashi is an employee of TES Holdings Co., Ltd.
